Enzyme replacement therapy for Anderson‐Fabry disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Enzyme Replacement Therapy for Anderson‐Fabry Disease." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436014/all/Enzyme_replacement_therapy_for_Anderson‐Fabry_disease.
Enzyme replacement therapy for Anderson‐Fabry disease. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436014/all/Enzyme_replacement_therapy_for_Anderson‐Fabry_disease. Accessed December 7, 2024.
Enzyme replacement therapy for Anderson‐Fabry disease. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436014/all/Enzyme_replacement_therapy_for_Anderson‐Fabry_disease
Enzyme Replacement Therapy for Anderson‐Fabry Disease [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 07]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436014/all/Enzyme_replacement_therapy_for_Anderson‐Fabry_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Enzyme replacement therapy for Anderson‐Fabry disease
ID - 436014
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436014/all/Enzyme_replacement_therapy_for_Anderson‐Fabry_disease
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -